Hip Pelvis.  2015 Mar;27(1):9-16. 10.5371/hp.2015.27.1.9.

Nonsurgical Treatment Strategies after Osteoporotic Hip Fractures

• Min BW
• Song KS
• Bae KC
• Cho CH
• Son ES
• Lee KJ

• KMID: 2156014
• DOI: http://doi.org/10.5371/hp.2015.27.1.9

Abstract

Osteoporosis is a metabolic disease that is increasing in prevalence as people live longer. Because the orthopedic surgeon is frequently the first and often the only physician to manage patients with osteoporotic hip fractures, every effort should be made to prevent future fractures. A multidisciplinary approach is essential in treatment of osteoporotic fractures. Basic treatment includes calcium and vitamin D supplementation, fall prevention, hip protection, and balance and exercise programs. Currently available pharmacologic agents are divided into antiresorptive and anabolic groups. Antiresorptive agents such as bisphosphonates limit bone resorption through inhibition of osteoclastic activity. Anabolic agents such as parathyroid hormone promote bone formation.

Keyword

Osteoporosis; Medication; Hip fractures

MeSH Terms

Anabolic Agents
Bone Density Conservation Agents
Bone Resorption
Calcium
Diphosphonates
Hip
Hip Fractures*
Humans
Metabolic Diseases
Orthopedics
Osteoclasts
Osteogenesis
Osteoporosis
Osteoporotic Fractures
Parathyroid Hormone
Prevalence
Vitamin D
Anabolic Agents
Bone Density Conservation Agents
Calcium
Diphosphonates
Parathyroid Hormone
Vitamin D